A new analysis from the Institute for Clinical and Economic Review said the evidence available to date shows moderate effectiveness of two newer drugs for myasthenia gravis—eculizumab and efgartigimod—but found their price exceedingly high and their use not cost-effective.
Get ready to turn your clocks back one hour this Sunday (Nov. 7) for Daylight Saving Time .
This fall we gain an hour and in the spring we’ll turn clocks
The number of people experiencing numbness, pins and needles, and burning pain in their feet and toes seems to be on the rise, new research suggests, and some of these folks may be at increased risk for heart trouble.
Observational evidence points towards earlier initiation of therapy, but a definitive answer awaits several RCTs.
The likelihood that opioid treatment for common neurological conditions was initiated appeared to decrease with greater access to neurologists or other specialists who offered alternative pain treatment.
One of the main reasons why millions of people drink coffee every day is because of its energy-boosting properties. Having trouble getting out of bed in the
"We’ve had multi-millions of cases of COVID in this country. I mean let’s do the math, when 20 percent of those individuals – we’re talking about millions of individuals who have long COVID, those individuals are really impaired." Dr. Eva Feldman speaks to One Detroit's Bill Kubota on Detroit Public Television about Long COVID.
What sleep experts say will help you get re-acclimated to a pre-pandemic schedule
Multidisciplinary group of U-M researchers will investigate environmental exposures, chosen as one of the first projects in a new NIH amyotrophic lateral sclerosis initiative.
Tiffany Braley, M.D., M.S. , an associate professor of neurology at University of Michigan Health, was surprised when a patient she was caring for explained why they needed to go home from the hospital as soon as possible: their pets.
University of Michigan (U-M) clinician-researchers, led by Roger Albin, MD, Anne B. Young Collegiate Professor of Neurology, Co-Director, U-M Movement Disorders Division, and Director, U-M Parkinson’s Foundation Research Center of Excellence, were awarded a five-year $11.7 million grant from the National Institute of Neurological Diseases and
Principal investigators Tiffany Braley MD, MS and Galit Levi Dunietz PhD, MPH were recently awarded $1.4M in new R01 funding by the National Institute on Aging to study unexplored pathways between obstructive sleep apnea (OSA), OSA treatment, and dementia risk in older women and men.
Principal investigators Tiffany Braley MD, MS (Neurology) and Anna Kratz PhD (Physical Medicine and Rehabilitation) were recently awarded $3.3M in new R01 funding from the National Center for Complimentary and Integrative Health to conduct research on the effects of cannabinoids on sleep and pain in people with MS.
The Michigan Alzheimer’s Disease Research Center received continued funding from the National Institutes of Health to continue its work across the state of Michigan for five more years.
More information can be found on their website
Dr. Roger Albin interviews with Crain's Detroit Business about Parkinson's Disease and its possible relation to viral infections.
Subscription may be required for full access.
Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for their new findings which could change the trajectory of treatment for key neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and
ANN ARBOR, Mich. — Michigan Medicine’s adult hospitals were ranked best in Michigan and 11th in the nation by U.S. News & World Report “Best Hospitals” rankings for 2021-2022. This prestigious honor measures excellence in patient care.
The American Neurological Association (ANA) , the professional organization representing the world’s top academic neurologists and neuroscientists, has announced the recipients of its 2021 scientific awards, to be presented during the 146th ANA Annual Meeting , which will be
